Cardiff Oncology (CRDF) Financials: Revenue & Earnings

CRDF price $0.90 +0.02 +2.57%

Ticker
CRDF
Price
$0.90
Change
+0.02 +2.57%
Market cap ?
$69.83M
Beta ?
1.42
Sector
Healthcare
Industry
Biotechnology

Fair value

CRDF fair value Not meaningful. Price $0.90.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare CRDF

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.14—81.43K
2026-08-11-0.14-0.12104.00K62.78K
2026-05-14-0.18-0.1341.00K88.57K
2026-02-24-0.11-0.18243.00K103.50K
2025-11-06-0.17-0.20120.00K103.50K
2025-07-29-0.21-0.19121.00K109.38K
2025-05-08-0.20-0.19109.00K89.29K
2025-02-27-0.21-0.26151.00K94.17K
2024-11-07-0.25-0.27165.00K70.00K
2024-08-08-0.26-0.25163.00K60.00K
2024-05-02-0.22-0.25205.00K70.00K
2024-02-29-0.21-0.26156.00K40.00K
2023-11-02-0.22-0.29141.00K40.00K
2023-08-09-0.25-0.27108.00K40.00K
2023-05-04-0.25-0.2383.00K60.00K
2023-03-02-0.20-0.25128.00K73.25K
2022-11-03-0.20-0.2793.00K68.20K
2022-08-04-0.24-0.2591.00K93.00K
2022-05-05-0.25-0.2374.00K56.60K
2022-02-24-0.23-0.17133.00K41.00K
2021-11-04-0.17-0.1786.00K30.00K
2021-08-05-0.17-0.1568.00K150.00K
2021-05-06-0.14-0.1472.00K150.00K
2021-02-25-0.19-0.15119.25K30.00K
2020-11-05-0.19-0.20136.40K136.40K
2020-08-11-0.51-0.2442.63K29.68K
2020-05-07-0.41—67.70K—
2020-02-27-0.51-0.5793.00K103.47K
2019-11-07-0.71-0.8451.69K59.69K
2019-08-08-0.79-0.53138.00K116.24K
2019-05-07-1.02-1.07162.00K169.53K
2019-03-06-1.09-1.0578.00K—
2018-11-07-1.08-1.9888.36K115.67K
2018-08-03-2.64-1.98111.81K74.54K
2018-05-08-6.48-8.28100.14K121.90K
2018-02-26-4.32-9.00185.00K253.12K
2017-11-09-8.64-10.08123.33K140.95K
2017-08-09-10.08-10.80102.01K100.99K
2017-05-10-19.44-17.2895.04K95.04K
2017-03-15-18.00-23.0468.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-23Alland LeilaOther0——
2026-07-14PACE GARY WBuy687.28K$1.461000.00K
2026-07-14PACE GARY WBuy687.28K$1.33914.09K
2026-07-14Mohindru ManiBuy34.36K$1.4650.00K
2026-07-14Mohindru ManiBuy34.36K$1.3345.70K
2026-06-18Mohindru ManiBuy24.70K$1.2129.89K
2026-06-18PACE GARY WBuy30.00K$1.2236.60K
2026-06-11Armitage James OBuy40.56K$1.5964.50K
2026-06-11White LaleBuy40.56K$1.5964.50K
2026-06-11TANNENBAUM RENEE PBuy40.56K$1.5964.50K
2026-06-11Markin Rodney SBuy40.56K$1.5964.50K
2026-06-11PACE GARY WBuy40.56K$1.5964.50K
2026-04-27Aggarwal AjayBuy400.00K$1.72688.00K
2026-04-27Aggarwal AjayOther0——
2026-04-14Smeal TodBuy300.00K$1.63489.00K
2026-04-06Muntner Joshua BOther0——
2026-04-06Muntner Joshua BBuy486.65K$1.58768.91K
2026-03-31Mohindru ManiBuy600.00K$1.62972.00K
2026-02-17Mohindru ManiBuy200.00K$1.56312.00K
2026-02-13Lindsay Brigitte UteBuy200.00K$1.60320.00K
2026-01-27Lindsay Brigitte UteOther0——
2026-01-27Lindsay Brigitte UteOther90.29K$1.72155.30K
2026-01-27Lindsay Brigitte UteOther95.04K$3.51333.59K
2026-01-27Lindsay Brigitte UteOther89.47K$2.48221.88K
2026-01-27Lindsay Brigitte UteOther1.75K$21.6037.86K
2026-01-27Lindsay Brigitte UteOther131.57K$2.50328.92K
2026-01-27Lindsay Brigitte UteOther154.70K$7.981.23M
2026-01-27Lindsay Brigitte UteOther96.19K$2.60250.10K
2026-01-27Lindsay Brigitte UteOther166.32K$3.58595.43K
2025-07-30PACE GARY WBuy15.00K$2.4536.75K
2025-07-30PACE GARY WBuy275.00K$2.45673.75K
2025-06-26TANNENBAUM RENEE PBuy40.56K$3.16128.19K
2025-06-26Markin Rodney SBuy40.56K$3.16128.19K
2025-06-26Mohindru ManiBuy40.56K$3.16128.19K
2025-06-26Armitage James OBuy40.56K$3.16128.19K
2025-06-26White LaleBuy40.56K$3.16128.19K
2025-06-26PACE GARY WBuy40.56K$3.16128.19K
2025-06-16Sidhu RogerOther600.00K$3.862.32M
2025-03-11Kabbinavar FairoozBuy150.00K$3.58537.00K
2025-03-11Levine James E.Buy332.62K$3.581.19M
2025-03-11Smeal TodBuy332.62K$3.581.19M
2025-03-11Erlander MarkBuy758.40K$3.582.72M
2024-12-18Levine James E.Buy2.40K$5.0012.00K
2024-12-17Levine James E.Buy2.75K$5.4214.91K
2024-12-16Levine James E.Buy2.56K$3.839.82K
2024-12-12TANNENBAUM RENEE PBuy10.00K$3.4234.22K
2024-12-11PACE GARY WBuy11.50K$2.6029.90K
2024-12-11PACE GARY WBuy350.12K$2.60910.30K
2024-06-27White LaleBuy29.70K$2.3369.20K
2024-06-27TANNENBAUM RENEE PBuy29.70K$2.3369.20K
2024-06-27Mohindru ManiBuy29.70K$2.3369.20K
2024-06-27PACE GARY WBuy29.70K$2.3369.20K
2024-06-27Armitage James OBuy29.70K$2.3369.20K
2024-06-27Markin Rodney SBuy29.70K$2.3369.20K
2024-03-07Levine James E.Buy205.01K$3.51719.58K
2024-03-07Kabbinavar FairoozBuy205.01K$3.51719.58K
2024-03-07Smeal TodBuy205.01K$3.51719.58K
2024-03-07Erlander MarkBuy510.00K$3.511.79M
2023-12-19PACE GARY WBuy30.00K$1.3741.10K
2023-11-10PACE GARY WBuy22.95K$0.9822.49K
2023-06-15Markin Rodney SBuy27.70K$1.5944.04K
2023-06-15Armitage James OBuy27.70K$1.5944.04K
2023-06-15White LaleBuy27.70K$1.5944.04K
2023-06-15PACE GARY WBuy27.70K$1.5944.04K
2023-06-15Mohindru ManiBuy27.70K$1.5944.04K
2023-06-15TANNENBAUM RENEE PBuy27.70K$1.5944.04K
2023-03-15Smeal TodBuy167.09K$1.72287.39K
2023-03-15Levine James E.Buy197.47K$1.72339.65K
2023-03-15Kelemen VickiBuy125.52K$1.72215.89K
2023-03-15Erlander MarkBuy482.06K$1.72829.15K
2023-01-30Kabbinavar FairoozSell425.00K$1.75743.75K
2022-11-25Erlander MarkBuy10.00K$1.4314.30K
2022-09-19White LaleBuy15.00K$1.6424.52K
2022-09-16Armitage James OBuy13.00K$1.5620.23K
2022-09-16Levine James E.Buy30.00K$1.5646.71K
2022-09-15TANNENBAUM RENEE PBuy3.60K$1.726.19K
2022-09-15TANNENBAUM RENEE PBuy6.40K$1.7210.98K
2022-09-15PACE GARY WBuy150.00K$1.71256.50K
2022-07-05White LaleBuy28.86K$2.6075.03K
2022-06-09BRANCACCIO JOHN PBuy223$516.96115.28K
2022-06-09BRANCACCIO JOHN PBuy223$372.9683.17K
2022-06-09BRANCACCIO JOHN PBuy530$51.8427.48K
2022-06-09BRANCACCIO JOHN PBuy22.00K$7.98175.56K
2022-06-09BRANCACCIO JOHN PBuy195$316.0861.64K
2022-06-09BRANCACCIO JOHN PBuy44.73K$2.48110.94K
2022-06-09BRANCACCIO JOHN PBuy28.86K$2.6075.03K
2022-06-09BRANCACCIO JOHN PBuy755$21.6016.31K
2022-06-09BRANCACCIO JOHN PBuy26.80K$2.5067.00K
2022-06-09BRANCACCIO JOHN PBuy22.00K——
2022-03-09PACE GARY WBuy26.80K——
2022-03-09PACE GARY WBuy26.80K$2.5067.00K
2022-03-09White LaleBuy26.80K——
2022-03-09TANNENBAUM RENEE PBuy26.80K$2.5067.00K
2022-03-09TANNENBAUM RENEE PBuy26.80K——
2022-03-09Ruffner Katherine LBuy170.02K——
2022-03-09Mohindru ManiBuy26.80K——
2022-03-09Mohindru ManiBuy26.80K$2.5067.00K
2022-03-09Markin Rodney SBuy26.80K——
2022-03-09Markin Rodney SBuy26.80K$2.5067.00K
2022-03-09Levine James E.Buy170.02K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 110, holders -10 vs prior quarter. Ownership 27.42%.

HolderSharesChangeChange %Value
LAURION CAPITAL MANAGEMENT LP3.10M451.56K+17.06%4.03M
VANGUARD CAPITAL MANAGEMENT LLC2.90M39.63K+1.39%3.76M
PFIZER INC2.41M00.00%3.01M
FRANKLIN TEMPLETON INC1.21M00.00%1.57M
BLACKROCK, INC.972.87K-3.01M-75.56%1.26M
BLAIR WILLIAM & CO/IL912.51K-9.89K-1.07%1.19M
GEODE CAPITAL MANAGEMENT, LLC820.06K-779.60K-48.74%1.07M
UBS GROUP AG638.70K238.12K+59.45%830.31K
JANE STREET GROUP, LLC607.90K567.79K+1415.77%790.27K
VANGUARD FIDUCIARY TRUST CO410.60K-35.62K-7.98%533.78K
AQR CAPITAL MANAGEMENT LLC346.35K280.20K+423.54%450.26K
STATE STREET CORP331.39K-855.55K-72.08%430.81K
HRT FINANCIAL LP272.79K272.79KNew354.00K
FLPUTNAM INVESTMENT MANAGEMENT CO247.47K-347.65K-58.42%321.72K
MORGAN STANLEY246.09K189.79K+337.07%319.92K
BNP PARIBAS FINANCIAL MARKETS228.46K215.38K+1647.18%297.00K
X-SQUARE CAPITAL, LLC205.70K205.70KNew267.00K
CITADEL ADVISORS LLC184.40K58.83K+46.86%239.72K
GSA CAPITAL PARTNERS LLP173.27K50.27K+40.86%225.00K
MARSHALL WACE, LLP162.21K162.21KNew210.88K
BANK OF NEW YORK MELLON CORP161.69K-141.74K-46.71%210.20K
NORTHERN TRUST CORP152.88K-340.33K-69.00%198.74K
AVESTAR CAPITAL, LLC136.15K00.00%176.99K
MILLENNIUM MANAGEMENT LLC134.52K111.49K+484.12%174.87K
QUBE RESEARCH & TECHNOLOGIES LTD125.55K125.55KNew163.22K

Earnings and financials

Cardiff Oncology, Inc. (CRDF) trades at $0.90, with a market cap of $69.83M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cardiff Oncology (CRDF) Financials: Revenue & Earnings

CRDF$0.90+0.02 +2.57%

$69.83M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History